Massimo Mischi is a Full Professor at the Faculty of Electrical Engineering of the Eindhoven University of Technology (TU/e) and chairs the Signal Processing Systems (SPS) Division , the largest division at TU/e with over 250 researchers. He founded the Biomedical Diagnostics (BM/d) Lab in 2012, which now includes 180 researchers and clinical/industrial advisors, focusing on biomedical signal processing for diagnostics and monitoring.
Professor Guy Williams is a leading academic at the University of Cambridge with a focus on imaging science and clinical neurosciences, affiliated with Downing College and the Wolfson Brain Imaging Centre . Holding a PhD in Physics from his initial Natural Sciences degree, he specializes in nuclear magnetic resonance (NMR) and MRI techniques for brain imaging. Education: BA, PhD in Physics His research centers on non-invasive imaging of brain structure and function, particularly in traumatic brain injury (TBI) and dementia. His work involves developing novel MRI pulse sequences and advanced data analysis algorithms, including AI-based diagnostic tools. He leads studies on white matter integrity post-trauma, longitudinal dementia assessment, and applications of MRI in disorders of consciousness and addiction. Recent publications highlight collaborations in traumatic brain injury outcomes, AI-guided dementia prediction, and neuroimaging of post-COVID cognitive deficits. His team's work on ultra-high field laminar fMRI and distortion correction methods has advanced clinical neuroscience applications. Key techniques include diffusion tensor imaging (DTI), 7 Tesla MRI, and positron emission tomography (PET/MR). His research spans from basic NMR physics to clinical translation, with a strong emphasis on multi-site studies and real-world diagnostic implementation.
Jonny Kohl is a Group Leader at the Francis Crick Institute , where he established the State-dependent Neural Processing Laboratory in 2019. His work bridges neural circuits and internal physiological states (e.g., hunger, pregnancy) to decode instinctive behaviors like parenting and aggression in mice. PhD: MRC Laboratory of Molecular Biology, Cambridge (2013) Postdoc: Harvard University (2014–2019) with support from EMBO, HFSP, and Wellcome Trust fellowships Research Interests : Kohl investigates how hormonal and metabolic states dynamically rewire neural circuits to drive adaptive behaviors. His lab combines circuit neuroscience , molecular biology , and behavioral profiling to study: State-dependent neural processing in parental behavior Chemosensory dominance hierarchies in mice Plasticity mechanisms in aggression circuits Development of ultrafast tissue labeling and cryoanesthesia tools Scientific Trends : His recent publications highlight hormone-mediated synaptic remodeling (2023), cost-effective lab tools (2023), and brain-wide activity mapping (2016). Collaborative work spans computational biology , metabolism , and imaging disciplines. Honors: NARSAD Young Investigator Award (2019), ERC Starting Grant (2019), Wellcome Trust Discovery Award (2025) Grants: BBSRC Research Grant (2025), BBSRC Pioneer Grant (2023) His lab mentors PhD and MSc students and has developed open-source neuroscience tools (e.g., cryoanesthesia device, 2023). Kohl's research has been featured in Nature , Science , and Cell .
Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .
Dr. Lucian Sulica is the Sean Parker Professor of Laryngology and Director of the Sean Parker Institute for the Voice at Weill Cornell Medical College. He is an attending Otolaryngologist at NewYork-Presbyterian Hospital with a clinical practice exclusively focused on voice disorders. Dr. Sulica served as the 2023 President of the American Laryngological Association and is a Fellow of the American Laryngologic, Rhinologic and Otologic Society (the Triologic Society). His educational background includes: A.B. from Dartmouth College (1989) M.D. from Georgetown University School of Medicine (1993) Residency at Georgetown University Medical Center Fellowship at New York Center for Voice & Swallowing Disorders, St. Luke's-Roosevelt Hospital Center Dr. Sulica's research focuses on evidence-driven principles for treating voice conditions, with particular emphasis on vocal fold injuries from voice use (especially in performers), neurologic voice disorders (including vocal fold paralysis, spasmodic dysphonia, and tremor), and in-office procedures for voice disorders that don't require general anesthesia. His work has addressed critical aspects such as gender differences in vocal fold injury, pathophysiology of laryngeal nerve injury, and diagnostic accuracy in voice disorders. Analysis of Dr. Sulica's recent publications reveals a strong focus on advancing diagnostic techniques through artificial intelligence, improving surgical outcomes for vocal fold lesions, understanding performers' unique voice care needs, and developing evidence-based protocols for vocal fold hemorrhage and other voice disorders. His research increasingly incorporates technology-driven approaches while maintaining a strong clinical focus on patient-centered outcomes. Dr. Sulica has received numerous prestigious awards including: Casselberry Award of the American Laryngological Association (2021) Felix Semon Lectureship in Laryngology, Royal Society of Medicine (2022) American Academy of Otolaryngology – Head & Neck Surgery Honor Award (2008) Consistent recognition as one of "Best Doctors in America" (2005-2024) Designation as one of "America's Top Physicians in Voice Disorders/Laryngology" (since 2006) Inclusion in "New York Magazine Best Doctors" list annually since 2013 As an educator, Dr. Sulica has authored more than 110 journal articles and 40 book chapters, and has edited three books including "Vocal Fold Paralysis," "Classics in Voice and Laryngology," and "Patologia Laringea y Fonocirugia" (in Spanish). He is passionate about teaching and has lectured extensively across the United States, Europe, Latin America, and Australia. His clinical work at the Sean Parker Institute for the Voice represents a comprehensive approach to voice care, incorporating innovative in-office procedures that have helped establish new standards in laryngology.
Evelyn Lake is an Associate Professor in the Department of Radiology and Biomedical Imaging at Yale University, with affiliations to the Wu Tsai Institute and Yale Biomedical Imaging Institute. Her research focuses on functional neuroimaging, particularly using rodent models to study brain connectivity, neurovascular coupling, and disorders like Alzheimer’s disease and autism spectrum disorder. PhD in Medical Biophysics, University of Toronto (2016) Postdoctoral Associate, Yale University (2019) BSc (Honors) in Biophysics, University of Guelph (2010) Her work spans multimodal imaging techniques (e.g., simultaneous Ca2+ and fMRI), examining how genetic mutations (e.g., PTEN, KATNAL2) affect cerebrospinal fluid dynamics and neuronal connectivity. She investigates longitudinal changes in Alzheimer’s models and methodological aspects of animal neuroimaging, such as sample size optimization and awake imaging protocols. Recent publications highlight her contributions to understanding autism-related white matter abnormalities, transdiagnostic connectome predictive modeling, and the impact of neurovascular uncoupling in awake mice. Collaborations include Todd Constable, Francesca Mandino, Xilin Shen, and Xenophon Papademetris.
Dr. Kanwaljeet S. Anand is a dual-appointed Professor of Pediatrics (Pediatric Critical Care) and Anesthesiology, Perioperative & Pain Medicine at Stanford University School of Medicine. As director of the Pain/Stress Neurobiology Lab and Jackson Vaughan Critical Care Research Fund, he serves as Editor-in-Chief of Pediatric Research and maintains active membership in Bio-X, MCHRI, and Wu Tsai Neurosciences Institute. Rhodes Scholar with D.Phil from University of Oxford Harvard postdoctoral fellowship and Boston Children's Hospital residency Founded Harmony Health Clinic - Arkansas' largest charitable medical-dental facility A translational researcher with 30+ years of impact, Dr. Anand established the first scientific framework for infant pain perception and developed novel pain assessment methodologies. Current research focuses on: Hair biomarker analysis for stress and social affiliation (cortisol/oxytocin) Machine learning systems for objective pain detection in non-verbal infants Biopsychosocial interventions for stress reduction in disadvantaged youth Neurotoxicity mechanisms of sedatives in developing brains Global NICU opioid usage patterns through the NeoOpioid Consortium His work has yielded over 260 publications and significant advances in: Pediatric pain management protocols Neonatal stress biomarker development Critical care neurobiology insights Community health initiatives AI-driven clinical decision support systems Scientific Recognition 9th Annual 'In Praise of Medicine' Public Address, Erasmus University (2014) Nightingale Excellence Award (2016) Honorary Doctorate from University of Örebro (2019) NIH SBIB-H82 Study Section Chair (2018) Multiple IASP and American Pain Society awards Swedish Academy of Medicine's Nils Rosén von Rosenstein Award (2009) St. Jude Endowed Chairholder (2010) As mentor to Med Scholar Anjali Gupta and advisor to numerous professional bodies, Dr. Anand maintains active clinical leadership in Pediatric Intensive Care while advancing computational approaches to pain detection through collaborations with Stanford's AI researchers.
Ingo Bojak is a Professor at the School of Psychology and Clinical Language Sciences , University of Reading. His research focuses on computational neuroscience, neurodynamics, and neural population models. He explores topics such as biological mistake-making, EEG analysis, and the effects of anesthesia on brain activity. Bojak serves as an associate editor for Neurocomputing and related journals. His work bridges theoretical frameworks with experimental data, emphasizing cross-scale biological phenomena and neural network dynamics. Bojak’s research interests include understanding spontaneous neural oscillations, cortical activity modeling, and the integration of EEG/fMRI data. He has contributed to advancements in neural field theory and Bayesian uncertainty quantification. His studies on biological mistakes highlight adaptive mechanisms across biological systems. Related affiliations include collaborations with the School of Biological Sciences at the University of Reading. Recent publications emphasize theoretical biology, computational neuroscience, and interdisciplinary approaches to understanding neural systems. His work often addresses functional adaptation through error-driven mechanisms and explores the interplay between neural excitability and inhibition.
Yan Ma serves as Professor and Chair of Biostatistics at the University of Pittsburgh, with additional appointments in Orthopaedic Surgery and Clinical and Translational Science. Previously, he was Professor and Vice Chair at George Washington University Milken Institute of Public Health (2014-2022) and Assistant Professor at Hospital for Special Surgery/Weill Cornell Medical College (2008-2014). His educational background includes: PhD in Statistics, University of Rochester (2008) MA in Statistics, University of Rochester (2004) MS in Mathematics, Syracuse University (2003) BS in Statistics, Beijing Normal University (2001) Ma's research centers on advanced statistical methodologies including missing data imputation, machine learning, meta-analysis, causal inference, and longitudinal methods, applied across orthopedics, anesthesiology, health disparities, and emergency medicine through team science and translational research frameworks. His publication trajectory demonstrates sustained innovation from methodological foundations (2008-2012) to contemporary applications in health disparities and machine learning (2016-2022), consistently addressing complex biomedical challenges through high-impact journals like JAMA and Health Services Research. His scientific recognition includes: ASA's Statistics in Epidemiology Young Investigator Award (2010) Interorganizational Team Science Award (2012) ORISE FDA Research Fellowship (2017) APHA Achievement in Academia Award Ma has secured R01 funding from NIH/AHRQ for missing data methods in health disparities research while serving as Associate Editor for ASA journals and reviewer for NIH/PCORI/VA panels, demonstrating leadership in statistical methodology development and interdisciplinary collaboration. His team-science approach bridges statistical innovation with clinical implementation across orthopedics and anesthesiology, driving evidence-based practice through methodological rigor and cross-disciplinary partnerships.
Martin M. Monti is a Professor of Psychology, Neurosurgery, and Psychiatry and Biobehavioral Sciences at the University of California Los Angeles (UCLA), affiliated with the College of Letters and Science. His research focuses on disorders of consciousness, traumatic brain injury (TBI), neuroimaging, and cognitive neuroscience. He holds an MA and PhD in Psychology & Neuroscience from Princeton University (2006–2007) and a BA in Economics from Università Commerciale L. Bocconi (2002). Key research interests include understanding consciousness recovery mechanisms, neuroimaging techniques for TBI assessment, and neuromodulation therapies. Recent work explores subcortical correlates of sleep quality, AI-driven models of consciousness, and transcranial focused ultrasound applications. Monti has received prestigious awards, including the UCLA Life Science Faculty Award (2020, 2014) and the International Prize Giuseppe Sciacca for Medical Research (2018). He leads interdisciplinary projects through collaborations like the ENIGMA working group and the Curing Coma Campaign, advancing global neuroimaging standards and translational research.
Dr. Stephanie Archer is an Associate Professor and Senior Research Associate at the University of Cambridge, jointly affiliated with the Department of Psychology and the Department of Public Health and Primary Care. Her work bridges psychological science with clinical applications, particularly in cancer risk assessment and digital health interventions. Dr. Archer holds a BSc, MSc, and PhD, though specific institutions are not mentioned in available sources. Her educational background has prepared her for interdisciplinary research at the intersection of psychology, public health, and clinical medicine. Her research focuses on three primary areas: designing multifactorial cancer risk prediction tools for clinical settings; exploring patient and staff experiences of health and social care; and developing/testing digital health interventions. She employs qualitative methods extensively while also engaging with quantitative approaches for comprehensive health services research. Her work demonstrates strong translational focus, moving from theoretical frameworks to practical clinical applications. Analysis of Dr. Archer's recent publications reveals a consistent trajectory in cancer risk prediction tools (particularly CanRisk), patient experience research across multiple conditions, and implementation science for digital health interventions. Her work spans breast, ovarian, prostate, and other cancers while also addressing mental health in autistic populations and patient safety in surgical settings. The interdisciplinary nature of her research connects psychology with oncology, primary care, and public health. Dr. Archer actively contributes to clinical guidelines development, as evidenced by her involvement in the Joint ABS-UKCGG-CanGene-CanVar consensus regarding CanRisk implementation. Her research methodology combines qualitative depth with mixed-methods approaches to address complex healthcare challenges. As a Senior Research Associate and Associate Professor, Dr. Archer likely supervises PhD students and early-career researchers, though specific advisees are not documented in available sources. Her teaching interests include health psychology, health services research, qualitative methods, and intervention development. Dr. Archer collaborates across multiple research units at Cambridge, including the Primary Care Unit and likely the Centre for Cancer Genetic Epidemiology, reflecting her interdisciplinary approach to improving cancer risk assessment and patient care pathways.
Dr. Junfang Wu is a Professor in the Department of Anesthesiology and holds a secondary appointment in Neurobiology at the University of Maryland School of Medicine. She serves as Associate Director of UM-MIND (University of Maryland - Medicine Institute for Neuroscience Discovery), Director of the Anesthesiology Center for Neuroscience Research, and Vice-Chair for Translational Research in the Department of Anesthesiology. Her academic journey includes a BM in Medicine, MS in Pharmacology from Jiangxi Medical College, and PhD in Neuropharmacology from Nanjing Medical University, followed by postdoctoral training at China's Institute of Materia Medica and NIH. Research Focus: Neurotrauma, neuroinflammation, autophagy-lysosomal pathway, extracellular vesicles, Hv1/NOX2/ROS, TrkB.T1 Key Techniques: Rodent models of SCI/TBI, behavioral evaluations, EV characterization, quantitative imaging, molecular/cellular biology Dr. Wu's research explores the cellular and molecular mechanisms of neurological dysfunction following CNS trauma, with emphasis on autophagy-lysosomal disruption, microglial Hv1 channels, and EV-mediated neuroinflammatory signaling. Her 2025 Aging and disease study reveals age-dependent transcriptional changes post-anesthesia, while 2024 Brain, Behavior, and Immunity work demonstrates how SCI alters EV cargoes to drive brain neuroinflammation. Her team recently discovered that Hv1 proton channel ablation in microglia provides neuroprotection in SCI models. Her scientific contributions are recognized through the 2025 Matjasko Professorship in Anesthesiology Research. She has secured multiple NIH grants including: R01 NS145443 (2025-2030): cGAS signaling in brain trauma-induced neuroinflammation R01 AG077541 (2022-2027): TBI olfactory dysfunction and dementia progression 2RF1 NS094527 (2016-2027): Autophagy mechanisms in SCI R01 NS110825 (2020-2026): Hv1 channel in SCI/TBI Dr. Wu's laboratory personnel include Research Associates Yun Li and Zhuofan Lei, Post-doctoral Fellows Balaji Krishnamachary and Zihui Wang, Research Assistant Hui Li, and medical student Ruth Park. Her work spans from bench research on lysosomal damage to clinical implications for Alzheimer's disease-related dementia (AD/ADRD) and potential therapeutic strategies.
Dr. Stanley J. Rogers is a Professor in the Department of Surgery at the University of California, San Francisco (UCSF), School of Medicine. He holds the Ruth M. Dunn Endowed Chair in Minimally Invasive Surgery and the His Majesty King Bhumibol Adulyadej, Rama IX Distinguished Professorship of Global Surgery. He serves as Interim Division Chief of General Surgery and directs the Bariatric Surgery Center, Liver Tumor Ablation Program, and Minimally Invasive Surgery Program. He is also a staff and trauma surgeon at Zuckerberg San Francisco General Hospital and Trauma Center, where he leads videoendoscopic surgery. University: University of California, San Francisco School: School of Medicine Department: Department of Surgery Role: Professor, Interim Division Chief, Director Email: stan.rogers@ucsf.edu Dr. Rogers' research and clinical expertise focus on minimally invasive and bariatric surgical techniques, particularly laparoscopic surgery, sleeve gastrectomy, gastric bypass, and liver tumor ablation. His work explores the metabolic and skeletal consequences of bariatric procedures, with a strong emphasis on calcium metabolism, bone health, and gut microbiome changes. He has contributed extensively to understanding complications and outcomes in gastrointestinal and metabolic surgery. His recent publications show a consistent trend in studying the long-term metabolic and skeletal impacts of bariatric surgery, particularly comparing sleeve gastrectomy and gastric bypass. Key themes include bone mineral density changes, calcium absorption, hormonal regulation (e.g., PYY), and the role of the gut microbiome. Many studies involve collaborations with endocrinologists and metabolic researchers, reflecting a multidisciplinary approach to surgical outcomes. Scientific Awards and Honors: Honorary Fellow, Royal College of Surgeons (2016) His Majesty King Bhumibol Adulyadej Rama IX Distinguished Professor of Global Surgery, UCSF (2012) Ruth M. Dunn Endowed Chair in Minimally Invasive Surgery, UCSF (2011) Fellow, American College of Surgeons (1995) Dr. Rogers has supervised numerous residents and fellows and is actively involved in clinical training. He has served as Principal Investigator and Co-Investigator on multiple NIH-funded grants, including studies on calcium absorption, sleeve gastrectomy effects, and anti-reflux surgery. His work has significant implications for improving postoperative care and long-term outcomes in bariatric patients. He is affiliated with several key programs at UCSF, including the Bariatric Surgery Center, the Liver Tumor Ablation Program, the Minimally Invasive Surgery Program, the Comprehensive Cancer Center, and the Institute for Global Health Sciences. His leadership extends to clinical trials on endoscopic techniques and bariatric revision surgery.
Vanessa Nomellini, MD, PhD is an Associate Professor in the Division of Burn, Trauma, Acute and Critical Care Surgery at UT Southwestern Medical Center. She joined UT Southwestern in 2023 as the director of research for her division and leader in the Critical Care Outcomes Research Translation (CORT) group. Education: Dr. Nomellini earned her MD and PhD in Cellular and Molecular Biochemistry from Loyola University. She completed her general surgery residency at the University of Wisconsin and Surgical Critical Care fellowship at the University of Pennsylvania. Research Interests: Her work focuses on immune dysfunction in critically ill patients, particularly sepsis and trauma-induced immunosuppression. She leads studies on immune recovery mechanisms and develops the ICU Recovery Program for long-term patient management. Her NIH-funded research (R35 NIGMS) investigates immune suppression through both animal models and human observational studies. Publications Trends: Her recent work emphasizes sepsis pathophysiology, coagulopathy management, and clinical improvements in critical care. Key areas include immunomodulatory therapies, biomarker utility, and optimizing ICU protocols. Scientific Awards: Recipient of NIGMS R35 grant (2019-current) Advising & Grants: Leads a multi-institutional research team and holds leadership roles in CORT. Her grants focus on translational immunology and critical care outcomes. Labs & Teams: Directs research at UT Southwestern's Critical Care Division, collaborating with Drs. Levi and Carlson in CORT initiatives.
Timothy B. Curry, M.D., Ph.D., is a Professor of Anesthesiology and Assistant Professor of Physiology at Mayo Clinic, Rochester, Minnesota. He holds academic roles including Vice Chair for Clinical Practice in the Department of Anesthesiology and Perioperative Medicine, and leads initiatives in individualized medicine through the Center for Individualized Medicine. His research focuses on autonomic nervous system regulation of cardiovascular and metabolic functions, employing advanced techniques such as microneurography and glucose clamping. Key interests include perioperative outcomes, environmental physiology, and hyperbaric medicine. Education: B.A. in Molecular Biology & Biochemistry (Middlebury College) M.D./Ph.D. via Medical Scientist Training Program (SUNY Buffalo) Residency in Anesthesiology (Mayo Clinic) Research Interests: Dr. Curry’s work spans autonomic nervous system physiology, metabolic syndrome mechanisms, and perioperative glycemic control. He leads the Human Integrative Physiology and Clinical Pharmacology Laboratory and collaborates globally on microneurography studies. Recent projects include investigating cerebral oxygen metabolism under hypoxia and developing genomic medicine training programs (COGENT). Awards: Emerald Award for Excellence (2015) Mayo Excellence in Leadership Award (2009) Multiple research and teaching accolades Grants & Leadership: Co-director of Mayo’s Clinomics Program, Team Leader for Perioperative Glucose Management, and Chair of multiple committees overseeing clinical practice and research. Labs & Teams: Directs the Human Integrative Physiology Lab and collaborates with the Clinical Research Unit. Active in multidisciplinary teams addressing autonomic dysfunction and precision medicine.